These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 8150318

  • 1. Migraine: possible role of platelet insensitivity to prostaglandin E1 (PGE1).
    Cerneca F, de Luyk S, Radillo O, Simeone R, Mangiarotti M.
    Funct Neurol; 1993; 8(6):403-8. PubMed ID: 8150318
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM, Holmsen H.
    Thromb Haemost; 1984 Dec 29; 52(3):333-5. PubMed ID: 6099615
    [Abstract] [Full Text] [Related]

  • 3. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
    Kikura M, Kazama T, Ikeda T, Sato S.
    Platelets; 2000 Dec 29; 11(8):446-58. PubMed ID: 11177444
    [Abstract] [Full Text] [Related]

  • 4. The effect of parenteral lipid emulsion-induced hyperlipidemia on prostaglandin E1 modulation of platelet function.
    Saladino CF, Kosacolsky-Singer C, Fox R, Nethala V, Feffer SE, Jonas EA.
    Artery; 1993 Dec 29; 20(6):303-13. PubMed ID: 8010886
    [Abstract] [Full Text] [Related]

  • 5. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1.
    Chirkov YY, Chirkova LP, Sage RE, Horowitz JD.
    J Cardiovasc Pharmacol; 1995 Jun 29; 25(6):961-6. PubMed ID: 7564342
    [Abstract] [Full Text] [Related]

  • 6. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
    Palma-Barqueros V, Torregrosa JM, Caparrós-Pérez E, Mota-Pérez N, Bohdan N, Llanos MDC, Begonja AJ, Sola-Visner M, Vicente V, Teruel-Montoya R, Rivera J, Ferrer-Marín F.
    Neonatology; 2020 Jun 29; 117(1):15-23. PubMed ID: 31786577
    [Abstract] [Full Text] [Related]

  • 7. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M, Zahavi J, Kakkar VV.
    Thromb Haemost; 1984 Oct 31; 52(2):205-9. PubMed ID: 6098048
    [Abstract] [Full Text] [Related]

  • 8. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV, Gorman RR.
    J Cyclic Nucleotide Res; 1976 Oct 31; 2(2):79-87. PubMed ID: 177467
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
    Khanna V, Armstrong PC, Warner TD, Curzen N.
    Platelets; 2015 Oct 31; 26(7):689-92. PubMed ID: 25734957
    [Abstract] [Full Text] [Related]

  • 10. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.
    Jap TS, Kwok CF, Wong MC, Chiang H.
    Diabetes Res; 1994 Oct 31; 27(1):39-46. PubMed ID: 7648795
    [Abstract] [Full Text] [Related]

  • 11. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.
    McDonald JW, Stuart RK.
    J Lab Clin Med; 1974 Jul 31; 84(1):111-21. PubMed ID: 4365532
    [Abstract] [Full Text] [Related]

  • 12. Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation.
    Kaiya H, Ofuji M, Nozaki M, Tsurumi K.
    Psychopharmacol Bull; 1990 Jul 31; 26(3):381-4. PubMed ID: 2177206
    [Abstract] [Full Text] [Related]

  • 13. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
    Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny JL, Aiach M, Gaussem P.
    Circulation; 2003 Aug 26; 108(8):989-95. PubMed ID: 12912815
    [Abstract] [Full Text] [Related]

  • 14. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
    Antonikov IM, Alekseev OV, Chernukh AM.
    Biull Eksp Biol Med; 1982 Apr 26; 93(4):11-3. PubMed ID: 6952942
    [Abstract] [Full Text] [Related]

  • 15. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC, Liao CH, Chang YW, Liou JT, Day YJ.
    Biochem Pharmacol; 2009 Apr 15; 77(8):1364-73. PubMed ID: 19426675
    [Abstract] [Full Text] [Related]

  • 16. [Synthesis of tritium-labelled prostaglandin E1 and its binding to human platelets].
    Shevchenko VP, Nagaev IIu, Vrzheshch PV, Ershov DE, Zaĭtsev SV.
    Bioorg Khim; 1988 Aug 15; 14(8):1075-85. PubMed ID: 3219124
    [Abstract] [Full Text] [Related]

  • 17. Effects of alpha-tocopherol on platelet membrane function in cystic fibrosis.
    Davis PB, Hubbard VS, Dieckman L, Boat TF, Stern RC, Doershuk CF.
    J Lab Clin Med; 1984 Aug 15; 104(2):203-12. PubMed ID: 6086795
    [Abstract] [Full Text] [Related]

  • 18. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
    Zahavi M, Zahavi J, Kakkar VV.
    Life Sci; 1984 Oct 01; 35(14):1497-503. PubMed ID: 6090838
    [Abstract] [Full Text] [Related]

  • 19. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA, Kappa JR, Sinha AK, Cottrell ED, Reiser HJ, Addonizio VP.
    J Lab Clin Med; 1987 Feb 01; 109(2):184-90. PubMed ID: 2433373
    [Abstract] [Full Text] [Related]

  • 20. Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis.
    Chirkov YY, Mishra K, Chandy S, Holmes AS, Kanna R, Horowitz JD.
    J Heart Valve Dis; 2006 Jan 01; 15(1):28-33. PubMed ID: 16480009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.